Sangamo Biosciences Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
22.19 Mil |
| Income |
-18.59 Mil |
| Net Profit Margin |
-83.77% |
| Return on Equity |
NA |
| Debt/Equity Ratio |
NA |
|
| Revenue/Share |
0.53 |
| Earnings/Share |
-0.45 |
| Book Value/Share |
NA |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 3.2 | 2.8 | 1.4 |
| 2nd Qtr | 4.7 | 2.8 | 2.6 |
| 3rd Qtr | 4.1 | 3.7 | 2.3 |
| 4th Qtr | 10.2 | 6.8 | 2.8 |
| Total | 22.2 | 16.2 | 9.1 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.17 | -$0.20 | -$0.15 |
| 2nd Qtr | -$0.11 | -$0.18 | -$0.15 |
| 3rd Qtr | -$0.12 | -$0.15 | -$0.11 |
| 4th Qtr | -$0.05 | -$0.06 | -$0.17 |
| Total | -$0.45 | -$0.59 | -$0.58 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -183% | -18% | --- |
| 2nd Qtr | 35% | 10% | 0% |
| 3rd Qtr | -9% | 17% | 27% |
| 4th Qtr | 58% | 60% | -55% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | 15% | -33% |
| 2nd Qtr | 39% | -20% |
| 3rd Qtr | 20% | -36% |
| 4th Qtr | 17% | 65% |
advertisement
Recent News